UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development

The Journal of pharmacology and experimental therapeutics, 2003-09, Vol.306 (3), p.821-827

2003

Volltextzugriff (PDF)

Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders

Trends in pharmacological sciences (Regular ed.), 2005, Vol.26 (1), p.27-35

2005

Volltextzugriff (PDF)

Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder

British journal of pharmacology, 2006-07, Vol.148 (5), p.565-578

2006

Volltextzugriff (PDF)

Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance

Trends in pharmacological sciences (Regular ed.), 2005-07, Vol.26 (7), p.352-360

2005

Volltextzugriff (PDF)

Desensitization of nicotinic acetylcholine receptors as a strategy for drug development

The Journal of pharmacology and experimental therapeutics, 2009-02, Vol.328 (2), p.364-370

2009

Volltextzugriff (PDF)

Cognitive dysfunction in neuropsychiatric disorders: Selected serotonin receptor subtypes as therapeutic targets

Behavioural brain research, 2008-12, Vol.195 (1), p.30-38

2008

Volltextzugriff (PDF)

Repeated exposures to low-level chlorpyrifos results in impairments in sustained attention and increased impulsivity in rats

Neurotoxicology and teratology, 2010-07, Vol.32 (4), p.415-424

2010

Volltextzugriff (PDF)

CNS Targets for multi-functional drugs in the treatment of Alzheimer's and Parkinson's diseases

Journal of Neural Transmission, 2005-04, Vol.112 (4), p.519-537

2005

Volltextzugriff (PDF)

Estimation of working memory in macaques for studying drugs for the treatment of cognitive disorders

Journal of Alzheimer's disease, 2008-12, Vol.15 (4), p.709-720

2008

Volltextzugriff (PDF)

Repeated, intermittent exposures to diisopropylfluorophosphate in rats: protracted effects on cholinergic markers, nerve growth factor-related proteins, and cognitive function

Neuroscience, 2011-03, Vol.176, p.237-253

2011

Volltextzugriff (PDF)

Microtubule-associated targets in chlorpyrifos oxon hippocampal neurotoxicity

Neuroscience, 2007-04, Vol.146 (1), p.330-339

2007

Volltextzugriff (PDF)

The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats

Biochemical pharmacology, 2012-04, Vol.83 (7), p.941-951

2012

Volltextzugriff (PDF)

Repeated exposures to subthreshold doses of chlorpyrifos in rats: hippocampal damage, impaired axonal transport, and deficits in spatial learning

The Journal of pharmacology and experimental therapeutics, 2003-04, Vol.305 (1), p.375-384

2003

Volltextzugriff (PDF)

Autoimmunity in Alzheimer’s disease: increased levels of circulating IgGs binding Aβ and RAGE peptides

Neurobiology of aging, 2004-09, Vol.25 (8), p.1023-1032

2004

Volltextzugriff (PDF)

Guidelines on nicotine dose selection for in vivo research

Psychopharmacologia, 2007-02, Vol.190 (3), p.269-319

2007

Volltextzugriff (PDF)

Chlorpyrifos, chlorpyrifos-oxon, and diisopropylfluorophosphate inhibit kinesin-dependent microtubule motility

Toxicology and applied pharmacology, 2007, Vol.218 (1), p.20-29

2007

Volltextzugriff (PDF)

Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties

The Journal of pharmacology and experimental therapeutics, 2005-09, Vol.314 (3), p.1274-1289

2005

Volltextzugriff (PDF)

Chronic, intermittent exposure to chlorpyrifos in rats: protracted effects on axonal transport, neurotrophin receptors, cholinergic markers, and information processing

The Journal of pharmacology and experimental therapeutics, 2007-09, Vol.322 (3), p.1117-1128

2007

Volltextzugriff (PDF)

Multiple central nervous system targets for eliciting beneficial effects on memory and cognition

The Journal of pharmacology and experimental therapeutics, 2000-11, Vol.295 (2), p.438

2000

Volltextzugriff (PDF)

A 24-h access I.V. self-administration schedule of morphine reinforcement and the estimation of recidivism: Pharmacological modification by arecoline

Neuroscience, 2007-11, Vol.149 (3), p.487-498

2007

Volltextzugriff (PDF)

Neuronal Nicotinic Receptor Subtypes: DEFINING THERAPEUTIC TARGETS

Molecular interventions, 2004-10, Vol.4 (5), p.285-295

Buccafusco, Jerry J

2004

Volltextzugriff (PDF)

A reversible model of the cognitive impairment associated with schizophrenia in monkeys: Potential therapeutic effects of two nicotinic acetylcholine receptor agonists

Biochemical pharmacology, 2009-10, Vol.78 (7), p.852-862

2009

Volltextzugriff (PDF)

Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys

Psychopharmacologia, 2005-06, Vol.179 (4), p.725-732

2005

Volltextzugriff (PDF)

Guidelines on nicotine dose selection for in vivo research

Psychopharmacology, 2007-02, Vol.190 (3), p.269-319

2007

Volltextzugriff (PDF)

The importance of brainstem cholinergic neurons in the pressor response to cocaine

The Journal of pharmacology and experimental therapeutics, 2005-01, Vol.312 (1), p.179-191

2005

Volltextzugriff (PDF)

1 – 25 von 288

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(254)
Mit Volltextzugriff
(228)

Publikationsform

Artikel
(284)
Texte
(4)

Sprache

Englisch
(288)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Animals
(187)
Science & Technology
(179)
Life Sciences & Biomedicine
(176)
Male
(138)
Rats
(126)
Biological And Medical Sciences
(114)
Neurosciences & Neurology
(108)
Neurosciences
(106)
Pharmacology & Pharmacy
(93)
Medical Sciences
(86)
Dose-Response Relationship, Drug
(65)
Pharmacology. Drug Treatments
(51)
Rats, Wistar
(43)
Humans
(42)
Blood Pressure - Drug Effects
(38)
Female
(38)
Blood Pressure
(36)
Fundamental And Applied Biological Sciences. Psychology
(35)
Macaca Mulatta
(35)
Neuropharmacology
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development

Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders

Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder

Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance

Desensitization of nicotinic acetylcholine receptors as a strategy for drug development

Cognitive dysfunction in neuropsychiatric disorders: Selected serotonin receptor subtypes as therapeutic targets

Repeated exposures to low-level chlorpyrifos results in impairments in sustained attention and increased impulsivity in rats

CNS Targets for multi-functional drugs in the treatment of Alzheimer's and Parkinson's diseases

Estimation of working memory in macaques for studying drugs for the treatment of cognitive disorders

Repeated, intermittent exposures to diisopropylfluorophosphate in rats: protracted effects on cholinergic markers, nerve growth factor-related proteins, and cognitive function

Microtubule-associated targets in chlorpyrifos oxon hippocampal neurotoxicity

The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats

Repeated exposures to subthreshold doses of chlorpyrifos in rats: hippocampal damage, impaired axonal transport, and deficits in spatial learning

Autoimmunity in Alzheimer’s disease: increased levels of circulating IgGs binding Aβ and RAGE peptides

Guidelines on nicotine dose selection for in vivo research

Chlorpyrifos, chlorpyrifos-oxon, and diisopropylfluorophosphate inhibit kinesin-dependent microtubule motility

Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties

Chronic, intermittent exposure to chlorpyrifos in rats: protracted effects on axonal transport, neurotrophin receptors, cholinergic markers, and information processing

Multiple central nervous system targets for eliciting beneficial effects on memory and cognition

A 24-h access I.V. self-administration schedule of morphine reinforcement and the estimation of recidivism: Pharmacological modification by arecoline

Neuronal Nicotinic Receptor Subtypes: DEFINING THERAPEUTIC TARGETS

A reversible model of the cognitive impairment associated with schizophrenia in monkeys: Potential therapeutic effects of two nicotinic acetylcholine receptor agonists

Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys

Guidelines on nicotine dose selection for in vivo research

The importance of brainstem cholinergic neurons in the pressor response to cocaine

Suchergebnisse filtern